NBIX

Neurocrine Biosciences (NBIX)

About Neurocrine Biosciences (NBIX)

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Details

Daily high

$137.01

Daily low

$134.12

Price at open

$134.98

52 Week High

$157.98

52 Week Low

$110.95

Market cap

13.7B

Dividend yield

0.00%

Volume

2.3M

Avg. volume

999,542

P/E ratio

36.28

Neurocrine Biosciences News